ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,832.55
-0.63%
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs Yen
156.945
-0.01%
Brent Oil
81.965
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. GeoVax Labs Inc (GOVXW)

  7. GeoVax Labs Inc (GOVXW) ニュース

GOVXW

GeoVax Labs (GOVXW)

GeoVax Labs Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:GOVXW
日付受信時刻ニュースソース見出しコード企業名
2024/05/2505 : 04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXWGeoVax Labs Inc
2024/05/2405 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXWGeoVax Labs Inc
2024/05/2206 : 23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXWGeoVax Labs Inc
2024/05/2201 : 32Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GOVXWGeoVax Labs Inc
2024/05/1605 : 03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXWGeoVax Labs Inc
2024/05/1506 : 09Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXWGeoVax Labs Inc
2024/05/1506 : 09Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXWGeoVax Labs Inc
2024/05/1506 : 08Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXWGeoVax Labs Inc
2024/05/1506 : 07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXWGeoVax Labs Inc
2024/05/1505 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GOVXWGeoVax Labs Inc
2024/04/0501 : 30GlobeNewswire Inc.GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 VaccineNASDAQ:GOVXWGeoVax Labs Inc
2024/03/2822 : 00GlobeNewswire Inc.GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine CongressNASDAQ:GOVXWGeoVax Labs Inc
2024/03/1222 : 00GlobeNewswire Inc.GeoVax to Present at the 36th Annual Roth ConferenceNASDAQ:GOVXWGeoVax Labs Inc
2024/03/0623 : 00GlobeNewswire Inc.GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing SystemNASDAQ:GOVXWGeoVax Labs Inc
2024/03/0106 : 00GlobeNewswire Inc.GeoVax Reports 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:GOVXWGeoVax Labs Inc
2024/02/2223 : 00GlobeNewswire Inc.GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024NASDAQ:GOVXWGeoVax Labs Inc
2024/02/1923 : 00GlobeNewswire Inc.GeoVax to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:GOVXWGeoVax Labs Inc
2024/02/1323 : 00GlobeNewswire Inc.GeoVax Announces Multiple Patent Issuances and AllowancesNASDAQ:GOVXWGeoVax Labs Inc
2024/02/0623 : 00GlobeNewswire Inc.GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine BoosterNASDAQ:GOVXWGeoVax Labs Inc
2024/01/2923 : 00GlobeNewswire Inc.GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementNASDAQ:GOVXWGeoVax Labs Inc
2024/01/0823 : 00GlobeNewswire Inc.GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, OncologyNASDAQ:GOVXWGeoVax Labs Inc
2024/01/0423 : 00GlobeNewswire Inc.GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer PatientsNASDAQ:GOVXWGeoVax Labs Inc
2024/01/0323 : 00GlobeNewswire Inc.GeoVax Announces Issuance of Malaria Vaccine PatentNASDAQ:GOVXWGeoVax Labs Inc
2023/12/2723 : 00GlobeNewswire Inc.GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024NASDAQ:GOVXWGeoVax Labs Inc
2023/12/1923 : 00GlobeNewswire Inc.GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and SmallpoxNASDAQ:GOVXWGeoVax Labs Inc
2023/12/0106 : 30GlobeNewswire Inc.GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine CongressNASDAQ:GOVXWGeoVax Labs Inc
2023/11/2923 : 00GlobeNewswire Inc.GeoVax to Participate in Upcoming December Investor EventsNASDAQ:GOVXWGeoVax Labs Inc
2023/11/2823 : 00GlobeNewswire Inc.GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine CongressNASDAQ:GOVXWGeoVax Labs Inc
2023/11/1423 : 00GlobeNewswire Inc.Progress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023NASDAQ:GOVXWGeoVax Labs Inc
2023/11/0906 : 00GlobeNewswire Inc.GeoVax Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:GOVXWGeoVax Labs Inc
 Showing the most relevant articles for your search:NASDAQ:GOVXW

最近閲覧した銘柄

AMEX
SPY
SPDR S&P 500
CCOM
SILVER
SILVER
COIN
BTCUSD
Bitcoin
NASDAQ
AMZN
Amazon.com
FX
USDEUR
US Dollar vs Euro
NYSE
VZ
Verizon Communications
NYSE
NKE
Nike
NYSE
AXP
American Express
CCOM
US100
US Tech 100
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
NYSE
BAC
Bank of America
PM
XAUUSD
Gold vs US Dollar
AMEX
XLV
Health Care Select Sector
NYSE
XOM
Exxon Mobil
FX
USDJPY
US Dollar vs Yen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有